US Drug Recall Register

FDA Drug Recalls

11,815 recalls · Class II, newest first

Class II · Moderate risk Terminated

Entertainer's Secret Throat Relief

Reason Microbial Contamination of Non Sterile Product; microbial assay reported unacceptable high plate counts and positive for E. Coli

Tropichem Research Labs, Inc. D-0328-2015
Class II · Moderate risk Terminated

Alprazolam tablets

Reason Subpotent Drug

Neolpharma, Inc. NDC 59762-3719-3 D-0326-2015
Class II · Moderate risk Terminated

J-TAN D PD Drops

Reason Labeling: Not Elsewhere Classified: Product is labeled "Dye Free" on front panel but contains Red Dye 40.

Jaymac Pharmaceuticals L.L.C. D-0327-2015
Class II · Moderate risk Terminated

Gabapentin Capsules

Reason Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

Actavis Elizabeth LLC NDC 45963-555-11 D-0338-2015
Class II · Moderate risk Terminated

Gabapentin Capsules

Reason Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

Actavis Elizabeth LLC NDC 45963-556-11 D-0337-2015
Class II · Moderate risk Terminated

Gabapentin Capsules

Reason Failed Capsule/Tablet Specifications: Actavis has received several complaint for clumping and breaking of capsules with some bottles showing popped out bottle bottom (round bottom) and creased labels from one distribution center.

Actavis Elizabeth LLC NDC 14550-513-02 D-0336-2015
Class II · Moderate risk Terminated

Hydroxocobalamin Injection Solution 1 mg/mL Inj.

Reason Presence of Particulate Matter; preservative may not have dissolved completely or precipitated out of product

American Specialty Pharmacy NDC 99999-9994-27 D-0427-2015
Class II · Moderate risk Terminated

Glutathione 200 mg/mL Injectable

Reason Incorrect Product Formulation: An incorrect gas was used to remove the oxygen from the vial.

Right Value Drug Stores, Inc. D-0335-2015
Class II · Moderate risk Terminated

Fentanyl Citrate Injection

Reason Lack of Assurance of Sterility; improperly crimped fliptop vials

Hospira Inc. NDC 0409-9094-61 D-0294-2015
Class II · Moderate risk Terminated

Tikosyn

Reason Failed Tablet/Capsule Specifications: Product being recalled due to the potential presence of cracked or broken capsules.

Pfizer Inc. NDC 0069-5800-61 D-0292-2015
Class II · Moderate risk Terminated

Benzonatate Capsules

Reason Failed Tablet/Capsule Specifications: Recall due to wet and/or leaking capsules.

Zydus Pharmaceuticals USA Inc NDC 68382-248-01 D-0299-2015
Class II · Moderate risk Terminated

Clinimix E 4.25/10 sulfite-free

Reason Lack of Assurance of Sterility; leaks were observed from the bag seam and port seal

Baxter Healthcare Corp. NDC 0338-1115-04 D-0301-2015
Class II · Moderate risk Terminated

HydrALAZINE Hydrochloride Tablets

Reason Presence of Foreign Substance: Par Pharmaceutical, Inc. is recalling one lot of HydrALAZINE Hydrochloride tablets due to the presence of small aluminum particles.

Par Pharmaceutical Inc. D-0332-2015
Class II · Moderate risk Terminated

Ginseng Kianpi Pil

Reason Marketed Without An Approved NDA/ANDA: FDA analysis found this product to contain undeclared dexamethasone and cyproheptadine which are FDA approved drugs making this product an unapproved drug.

One and Zen D-0329-2015
Class II · Moderate risk Terminated

Mercaptopurine Tablets

Reason Failed USP Dissolution Test Requirements: This sub-recall is in response to Prometheus Laboratories Inc. recall for Mercaptopurine USP 50mg because the lot does not meet the specification for dissolution.

American Health Packaging NDC 68084-325-21 D-0300-2015
Class II · Moderate risk Terminated

Zonisamide active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-960-2015
Class II · Moderate risk Terminated

Zolmitriptan active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-959-2015
Class II · Moderate risk Terminated

Zoledronic Acid active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-958-2015
Class II · Moderate risk Terminated

Zinc Pyrithione active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-957-2015
Class II · Moderate risk Terminated

Zidovudine active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-956-2015
Class II · Moderate risk Terminated

Voriconazole active pharmaceutical ingredient packaged in varying…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-955-2015
Class II · Moderate risk Terminated

Vincristine Sulfate active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-954-2015
Class II · Moderate risk Terminated

Vidarbine Monophosphate active pharmaceutical ingredient packaged…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-953-2015
Class II · Moderate risk Terminated

Venlafaxine HCl active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-952-2015
Class II · Moderate risk Terminated

Vecuronium Bromide active pharmaceutical ingredient packaged in…

Reason Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Attix Pharmaceuticals D-951-2015